title: Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trials.
abstract: An analysis of subjects with concurrent bacteraemia and either nosocomial pneumonia, complicated intra-abdominal infection or complicated urinary tract infection from six phase 3 clinical trials demonstrated similar cure rates and clearance of bacteraemia in patients treated with doripenem and comparator agents.
authors: Janssen Medical Affairs, Raritan, NJ, USA. drice2@its.jnj.com
authors: Dennis A K
authors: DA
authors: Rice
authors: Koné
authors: K
authors: Kaniga
authors: Michael
authors: M
authors: Lee
authors: Rebecca
authors: R
authors: Redman
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016470:Bacteremia / Q000188:drug therapy* / Q000382:microbiology; D015780:Carbapenems / Q000627:therapeutic use*; D003428:Cross Infection / Q000188:drug therapy* / Q000382:microbiology; D000077726:Doripenem; D005260:Female; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use; D059413:Intraabdominal Infections / Q000188:drug therapy / Q000382:microbiology; D008297:Male; D000077731:Meropenem; D015242:Ofloxacin / Q000627:therapeutic use; D011014:Pneumonia / Q000188:drug therapy / Q000382:microbiology; D013845:Thienamycins / Q000627:therapeutic use; D016896:Treatment Outcome; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents; D015780:Carbapenems; D013845:Thienamycins; D015378:Imipenem; D015242:Ofloxacin; D000077726:Doripenem; D000077731:Meropenem